Jeffrey Dayno
-
Plymouth Meeting Pharmaceutical Company Eyes $1B Milestone
Harmony Biosciences says its flagship narcolepsy drug is on track to hit a major milestone, writes John George for The Philadelphia Business Journal. The Plymouth…
-
Devon’s Zynerba Secured in $2 Million Deal by Harmony Biosciences
Devon-based Zynerba is set to be acquired by Harmony Biosciences Holdings in a $2 million deal, writes John George for the Philadelphia Business Journal. …
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
